Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | dihydrofolate reductase | 0.0045 | 0.0159 | 0.0887 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0045 | 0.0159 | 0.0887 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.0297 | 0.168 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0047 | 0.0175 | 0.0511 |
Trichomonas vaginalis | thymidine kinase, putative | 0.1045 | 0.8442 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.1151 | 0.6578 |
Echinococcus multilocularis | transfer RNA-Ile | 0.0237 | 0.1748 | 1 |
Brugia malayi | hypothetical protein | 0.0431 | 0.3353 | 1 |
Loa Loa (eye worm) | runx1 | 0.0054 | 0.0234 | 0.0698 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0155 | 0.1071 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0155 | 0.1071 | 0.1034 |
Brugia malayi | dihydrofolate reductase family protein | 0.0045 | 0.0159 | 0.0462 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.1151 | 0.6578 |
Entamoeba histolytica | thymidine kinase, putative | 0.1045 | 0.8442 | 0.5 |
Mycobacterium ulcerans | thymidylate synthase | 0.011 | 0.0699 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.0297 | 0.0875 |
Echinococcus granulosus | Thymidine kinase 2 mitochondrial | 0.0237 | 0.1748 | 1 |
Brugia malayi | RNA binding protein | 0.0062 | 0.0297 | 0.0875 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.0297 | 0.168 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.0297 | 0.168 |
Loa Loa (eye worm) | thymidylate synthase | 0.011 | 0.0699 | 0.2084 |
Onchocerca volvulus | 0.0431 | 0.3353 | 1 | |
Trypanosoma brucei | thymidine kinase | 0.1045 | 0.8442 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0155 | 0.1071 | 0.5 |
Brugia malayi | thymidylate synthase | 0.011 | 0.0699 | 0.2075 |
Trypanosoma cruzi | thymidine kinase, putative | 0.1045 | 0.8442 | 1 |
Echinococcus granulosus | thymidylate synthase | 0.011 | 0.0699 | 0.3985 |
Schistosoma mansoni | survival motor neuron protein | 0.0047 | 0.0175 | 0.0982 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.0297 | 0.168 |
Schistosoma mansoni | dihydrofolate reductase | 0.0045 | 0.0159 | 0.0887 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.011 | 0.0699 | 1 |
Onchocerca volvulus | 0.011 | 0.0699 | 0.2075 | |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0155 | 0.1071 | 0.5 |
Echinococcus multilocularis | thymidine kinase | 0.0237 | 0.1748 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.0297 | 0.0885 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.0004 | 0.0012 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0045 | 0.0159 | 0.5 |
Schistosoma mansoni | thymidine kinase | 0.0237 | 0.1748 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.0297 | 0.168 |
Schistosoma mansoni | lozenge | 0.0054 | 0.0234 | 0.132 |
Brugia malayi | Dihydrofolate reductase | 0.0045 | 0.0159 | 0.0462 |
Onchocerca volvulus | 0.0047 | 0.0175 | 0.0511 | |
Trichomonas vaginalis | thymidine kinase, putative | 0.1045 | 0.8442 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.0297 | 0.168 |
Trypanosoma cruzi | thymidine kinase, putative | 0.1045 | 0.8442 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.023 | 0.1691 | 0.9673 |
Echinococcus multilocularis | Protein lozenge | 0.0054 | 0.0234 | 0.132 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.011 | 0.0699 | 0.3985 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0045 | 0.0159 | 0.0473 |
Trichomonas vaginalis | thymidine kinase, putative | 0.1045 | 0.8442 | 1 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.011 | 0.0699 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0004 | 0.0012 |
Brugia malayi | hypothetical protein | 0.0052 | 0.0221 | 0.0647 |
Echinococcus granulosus | thymidine kinase | 0.0237 | 0.1748 | 1 |
Brugia malayi | hypothetical protein | 0.023 | 0.1691 | 0.5037 |
Echinococcus multilocularis | geminin | 0.0165 | 0.1151 | 0.6578 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0052 | 0.0221 | 0.1148 |
Echinococcus multilocularis | thymidylate synthase | 0.011 | 0.0699 | 0.3985 |
Loa Loa (eye worm) | hypothetical protein | 0.023 | 0.1691 | 0.5042 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.0297 | 0.168 |
Loa Loa (eye worm) | hypothetical protein | 0.0431 | 0.3353 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0101 | 0.0626 | 0.3568 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.0297 | 0.0885 |
Echinococcus granulosus | thymidine kinase | 0.0237 | 0.1748 | 1 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.0297 | 0.0875 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.0004 | 0.0012 |
Loa Loa (eye worm) | hypothetical protein | 0.0431 | 0.3353 | 1 |
Echinococcus multilocularis | thymidine kinase | 0.0237 | 0.1748 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.023 | 0.1691 | 0.9673 |
Leishmania major | thymidine kinase, putative | 0.1045 | 0.8442 | 1 |
Echinococcus granulosus | geminin | 0.0165 | 0.1151 | 0.6578 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.0297 | 0.0885 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.0175 | 0.0982 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.